Related Experiment Videos
Summary
Researchers engineered Bacillus subtilis to secrete human interferon alpha 2 (IFN-alpha 2). This novel gene fusion approach successfully produced biologically active IFN-alpha 2, demonstrating a viable method for protein secretion.
Area of Science:
- Molecular Biology
- Biotechnology
- Protein Engineering
Background:
- Human interferon alpha 2 (IFN-alpha 2) is a crucial therapeutic protein.
- Efficient and scalable production of recombinant proteins is essential for pharmaceutical applications.
- Bacillus subtilis offers a robust platform for microbial protein expression and secretion.
Purpose of the Study:
- To develop a method for secreting mature human interferon alpha 2 (IFN-alpha 2) using Bacillus subtilis.
- To investigate the feasibility of a hybrid gene construct for directed protein secretion.
- To assess the biological activity of the secreted IFN-alpha 2.
Main Methods:
- Constructed a hybrid gene fusing the alpha-amylase signal peptide sequence to mature IFN-alpha 2.
- Transformed Bacillus subtilis with the engineered hybrid gene.
- Cultured the transformed bacteria and measured the secreted protein yield and antiviral activity.
Main Results:
- The hybrid preprotein was accurately cleaved at the signal peptide sequence.
- Secreted IFN-alpha 2 was obtained at concentrations of 0.5--1 mg per liter.
- The secreted IFN-alpha 2, regardless of short N-terminal extensions (1 or 6 amino acids), retained specific antiviral activity comparable to native IFN-alpha 2.
Conclusions:
- Bacillus subtilis can be effectively engineered to secrete biologically active human interferon alpha 2.
- The alpha-amylase signal peptide facilitates precise cleavage and secretion of functional IFN-alpha 2.
- This approach provides a promising strategy for the recombinant production of therapeutic proteins.